<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><front><journal-meta><journal-id journal-id-type="nlm-ta">Mol Med Rep</journal-id><journal-id journal-id-type="iso-abbrev">Mol Med Rep</journal-id><journal-id journal-id-type="pmc-domain-id">1932</journal-id><journal-id journal-id-type="pmc-domain">mmr</journal-id><journal-title-group><journal-title>Molecular Medicine Reports</journal-title></journal-title-group><issn pub-type="ppub">1791-2997</issn><issn pub-type="epub">1791-3004</issn><publisher><publisher-name>Spandidos Publications</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC6797990</article-id><article-id pub-id-type="pmcid-ver">PMC6797990.1</article-id><article-id pub-id-type="pmcaid">6797990</article-id><article-id pub-id-type="pmcaiid">6797990</article-id><article-id pub-id-type="pmid">31545433</article-id><article-id pub-id-type="doi">10.3892/mmr.2019.10672</article-id><article-id pub-id-type="publisher-id">mmr-20-05-4067</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group></article-categories><title-group><article-title>Dihydroartemisinin inhibits multiplication of <italic toggle="yes">Brucella suis</italic> vaccine strain 2 in murine microglia BV2 cells via stimulation of caspase-dependent apoptosis</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Yang</surname><given-names initials="J">Juan</given-names></name><xref ref-type="aff" rid="af1-mmr-20-05-4067">1</xref><xref rid="fn1-mmr-20-05-4067" ref-type="author-notes">*</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Li</surname><given-names initials="H">Haining</given-names></name><xref ref-type="aff" rid="af1-mmr-20-05-4067">1</xref><xref rid="fn1-mmr-20-05-4067" ref-type="author-notes">*</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wang</surname><given-names initials="Z">Zhao</given-names></name><xref ref-type="aff" rid="af1-mmr-20-05-4067">1</xref><xref rid="fn1-mmr-20-05-4067" ref-type="author-notes">*</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Yu</surname><given-names initials="L">Liming</given-names></name><xref ref-type="aff" rid="af1-mmr-20-05-4067">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Liu</surname><given-names initials="Q">Qiang</given-names></name><xref ref-type="aff" rid="af1-mmr-20-05-4067">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Niu</surname><given-names initials="X">Xiaoyan</given-names></name><xref ref-type="aff" rid="af1-mmr-20-05-4067">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Xu</surname><given-names initials="T">Ting</given-names></name><xref ref-type="aff" rid="af1-mmr-20-05-4067">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wang</surname><given-names initials="Z">Zhenhai</given-names></name><xref ref-type="aff" rid="af1-mmr-20-05-4067">1</xref><xref ref-type="aff" rid="af2-mmr-20-05-4067">2</xref><xref rid="c1-mmr-20-05-4067" ref-type="corresp"/></contrib></contrib-group><aff id="af1-mmr-20-05-4067"><label>1</label>Department of Neurology, The General Hospital of Ningxia Medical University, Yinchuan, Ningxia Hui Autonomous Region 750004, P.R. China</aff><aff id="af2-mmr-20-05-4067"><label>2</label>Ningxia Key Laboratory of Cerebrocranial Diseases, Incubation Base of National Key Laboratory, Yinchuan, Ningxia Hui Autonomous Region 750004, P.R. China</aff><author-notes><corresp id="c1-mmr-20-05-4067"><italic toggle="yes">Correspondence to</italic>: Dr Zhenhai Wang, Department of Neurology, The General Hospital of Ningxia Medical University, 804 South Shengli Street, Yinchuan, Ningxia Hui Autonomous Region 750004, P.R. China, E-mail: <email>wangzhenhai1968@163.com</email></corresp><fn id="fn1-mmr-20-05-4067"><label>*</label><p>Contributed equally</p></fn></author-notes><pub-date pub-type="ppub"><month>11</month><year>2019</year></pub-date><pub-date pub-type="epub"><day>11</day><month>9</month><year>2019</year></pub-date><volume>20</volume><issue>5</issue><issue-id pub-id-type="pmc-issue-id">343963</issue-id><fpage>4067</fpage><lpage>4072</lpage><history><date date-type="received"><day>28</day><month>11</month><year>2018</year></date><date date-type="accepted"><day>26</day><month>7</month><year>2019</year></date></history><pub-history><event event-type="pmc-release"><date><day>11</day><month>09</month><year>2019</year></date></event><event event-type="pmc-live"><date><day>22</day><month>10</month><year>2019</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-04-20 02:25:37.377"><day>20</day><month>04</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>Copyright: &#169; Yang et al.</copyright-statement><copyright-year>2019</copyright-year><license license-type="open-access"><license-p>This is an open access article distributed under the terms of the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">Creative Commons Attribution-NonCommercial-NoDerivs License</ext-link>, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="mmr-20-05-4067.pdf"/><abstract><p>Brucellosis, caused by a facultative intracellular parasite <italic toggle="yes">Brucella species</italic>, is the most common bacterial zoonotic infection worldwide. <italic toggle="yes">Brucella</italic> can survive and proliferate in several phagocytic and non-phagocytic cell types. Human brucellosis has similar clinical symptoms with systemic diseases, which may lead to delay of diagnosis and increasing of complications. Therefore, investigating the proliferation of <italic toggle="yes">Brucella</italic> in host cells is important to understand the pathogenesis of the disease. Dihydroartemisinin (DHA), a semi-synthetic derivative of artemisinin, has been recommended by World Health Organization as an anti-malarial drug. However, there have been few studies regarding its effectiveness against bacteria. In the present study, it was revealed that <italic toggle="yes">B. suis</italic> vaccine strain 2 (S2) grew in BV2 cells without significant cytotoxicity, and less than 20 &#181;M DHA had no inhibitory effects on BV2 cells. Furthermore, DHA reduced <italic toggle="yes">B. suis</italic> S2 growth in BV2 cells, and increased the percentage of apoptosis and the expression of cleaved caspase-3 in <italic toggle="yes">B. suis</italic> S2-infected cells. Collectively, the present data indicated that DHA induced the caspase-dependent apoptotic pathway to inhibit the intracellular <italic toggle="yes">B. suis</italic> S2 growth.</p></abstract><kwd-group><kwd>dihydroartemisinin</kwd><kwd><italic toggle="yes">B. suis</italic> s2</kwd><kwd>BV2 cells</kwd><kwd>apoptosis</kwd><kwd>caspase-3</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Brucellosis, caused by a facultative intracellular parasite <italic toggle="yes">Brucella species</italic>, is the most common bacterial zoonotic infection worldwide (<xref rid="b1-mmr-20-05-4067" ref-type="bibr">1</xref>,<xref rid="b2-mmr-20-05-4067" ref-type="bibr">2</xref>). Brucella can survive and proliferate in several phagocytic and non-phagocytic cell types, including macrophages, dendritic cells, placental trophoblasts <italic toggle="yes">in vivo</italic>, and has the ability to replicate in a variety of mammalian cells, such as microglia, fibroblasts, epithelial and endothelial cells (<xref rid="b3-mmr-20-05-4067" ref-type="bibr">3</xref>). In China, Brucellosis represents a major challenge from the last decade, and a high incidence of human brucellosis has been reported in northwestern China (<xref rid="b4-mmr-20-05-4067" ref-type="bibr">4</xref>). Human brucellosis has similar clinical symptoms with systemic diseases and can lead to delay in diagnosis and may increase unexpected complications (<xref rid="b5-mmr-20-05-4067" ref-type="bibr">5</xref>). Therefore, investigating the proliferation of <italic toggle="yes">Brucella</italic> in host cells is important to understand the pathogenesis of the disease. In addition, earlier evidence indicates that <italic toggle="yes">Brucella</italic> inhibits apoptosis of host cells to maintain an intracellular niche for its replication (<xref rid="b6-mmr-20-05-4067" ref-type="bibr">6</xref>). Therefore, induction of apoptosis in the host cells may provide a useful therapeutic strategy for the treatment of Brucellosis.</p><p>Dihydroartemisinin (DHA), a semi-synthetic derivative of artemisin, has been recommended by World Health Organization as an anti-malarial drug (<xref rid="b7-mmr-20-05-4067" ref-type="bibr">7</xref>). Previous studies have documented that DHA possesses the ability to prevent angiogenesis (<xref rid="b8-mmr-20-05-4067" ref-type="bibr">8</xref>), cause cell cycle arrest (<xref rid="b9-mmr-20-05-4067" ref-type="bibr">9</xref>), promote apoptosis, and inhibit cancer invasion (<xref rid="b10-mmr-20-05-4067" ref-type="bibr">10</xref>). However, there have been few studies regarding its effectiveness against bacteria.</p><p>In the present study, it was investigated whether DHA inhibited the intracellular growth of <italic toggle="yes">Brucella suis</italic> vaccine strain 2 (<italic toggle="yes">B. suis</italic> S2) in murine microglia BV2 cells, and whether the inhibitory effect of DHA was associated with stimulation of apoptosis of BV2 cells.</p></sec><sec sec-type="materials|methods"><title>Materials and methods</title><sec><title/><sec><title>Cell line and bacteria</title><p>Murine microglia BV2 cells were obtained from China Center for Type Culture Collection and cultured with Dulbecco's modified Eagle's medium (DMEM; Gibco; Thermo Fisher Scientific, Inc.) containing 10% fetal bovine serum (FBS; Hyclone; GE Healthcare Life Sciences), 2 mM glutamine, and 200 mM streptomycin/penicillin and maintained in 5% CO<sub>2</sub> at 37&#176;C. <italic toggle="yes">B. suis</italic> S2 was provided by Professor Xu from Ningxia Medical University (Yinchuan, China) and was grown in Soybean-Casein Digest Agar Medium (TSA) at 37&#176;C in a 5% CO<sub>2</sub> incubator. The single <italic toggle="yes">B. suis</italic> S2 colony was inoculated in sterilized tryptic soy broth (TSB) solution at 37&#176;C in a 5% CO<sub>2</sub> atmosphere until its use. Bacteria were harvested by centrifugation for 20 min at 2,000 &#215; g at 4&#176;C and washed twice with phosphate-buffered saline (PBS). Bacterial density in the cultures were estimated by the McFarland standards of bioM&#233;rieux, Inc. All bacterial experiments were carried out at the Biosafety Level 2 Laboratory (Key Laboratory of Pathogenic Microorganisms, The general hospital of Ningxia Medical University).</p></sec><sec><title>In vitro infection and DHA treatment</title><p>A total of 2&#215;10<sup>5</sup> BV2 cells were seeded in 6-well culture plates. After reaching 60% confluence, the cells were exposed to <italic toggle="yes">B. suis</italic> S2 at a multiplicity of infection (MOI) of 100 for 2 h in medium without antibiotics. Subsequently, BV2 cells were extensively washed to remove extracellular bacteria, and infection was maintained for 24 h in the presence of 100 &#181;g/ml gentamicin to kill remaining extracellular bacteria (<xref rid="b11-mmr-20-05-4067" ref-type="bibr">11</xref>). Two hours after infection, the cells were treated with different concentrations of DHA (0, 10, 20, 30 and 40 &#181;M).</p></sec><sec><title>Colony-forming unit assay (CFU assay)</title><p>The TSA was prepared according to the manufacturer's instructions and autoclaved at 120&#176;C for 30 min. On a clean bench, ~25 ml of TSA was poured into a 90-mm<sup>2</sup> sterile culture plate, inverted after coagulation, and used for bacterial culture. BV2 cells were infected with <italic toggle="yes">B. suis</italic> S2 at MOI 100 for 24 h, washed with PBS twice and lysed in 0.3% Triton-X100 for 10 min. The sample was inoculated on TSA media for 72 h, and the cell suspension was diluted to count the number of colonies. The visible colonies with a diameter greater than 1 mm were manually counted with an optical microscope.</p></sec><sec><title>Cell viability assay</title><p>Cell viability was determined by Cell-counting Kit-8 (CCK-8; BestBio) assay according to the manufacturer's protocol (<xref rid="b12-mmr-20-05-4067" ref-type="bibr">12</xref>). In brief, cells (1&#215;10<sup>4</sup>) were seeded in 96-well culture plates and cultured overnight. The cells were treated with different concentrations of DHA (0, 10, 20, 40 and 80 &#181;M) for 24 h, and the CCK-8 solution was added to each well and incubated for an additional 4 h. The absorbance at 450 nm was measured by Microplate reader (BioTek Instruments, Inc.) (<xref rid="b13-mmr-20-05-4067" ref-type="bibr">13</xref>).</p></sec><sec><title>Lactate dehydrogenase (LDH) assay</title><p>The toxicity of BV2 cells after <italic toggle="yes">B. suis</italic> S2 infection was determined by the LDH assay using a commercially available kit (Sigma-Aldrich; Merck KGaA) (<xref rid="b14-mmr-20-05-4067" ref-type="bibr">14</xref>). Briefly, the BV2 cells were infected with <italic toggle="yes">B. suis</italic> S2 at MOI 100 or exposure to different concentrations of DHA (0, 10, 20, 30 and 40 &#181;M) for 24 h. Finally, the supernatant was collected for the LDH assay.</p></sec><sec><title>Flow cytometric assay</title><p>The BV2 cells were infected with <italic toggle="yes">B. suis</italic> S2 and then stained with Annexin V/PI according to manufacturer's protocol (BestBio). The apoptosis in cells was analyzed by flow cytometric analysis (FCM).</p></sec><sec><title>Western blot analysis</title><p>Cells were harvested, washed twice with PBS, and lysed in RIPA buffer (Nanjing KeyGen Biotech Co., Ltd.). Protein concentration in the lysates was determined by the bicinchoninic acid (BCA) method according to the manufacturer's recommendations (Nanjing KeyGen Biotech Co., Ltd.). Protein (30 &#181;g) was separated on 12% Mini-Protean TGX gels and subsequently transferred onto a polyvinylidene difluoride (PVDF) membrane according to standard protocols. Caspase-3 (ID product code ab184787; dilution in 1:1,000), cleaved caspase-3 (ID product code ab49822; dilution in 1:500) or GAPDH (ID product code ab181602; dilution in 1:5,000; All from Abcam) antibodies were used for protein detection. Goat anti-mouse polyclonal antibody (Beijing Zhongshan Golden Bridge Biotechnology Co., Ltd.; OriGene Technologies; ZB-2305; dilution 1:5,000) was used as a secondary antibody. The blot was developed using the Western Lightning Ultra chemiluminescent substrate from Bio-Rad Laboratories, Inc., and detected using EpiChemi3 darkroom (UVP BioImaging Systems).</p></sec><sec><title>Antimicrobial susceptibility testing</title><p>The single clone was added to 5 ml TSB, incubated in a 37&#176;C incubator for 24 h, and the concentration of the bacteria suspensions was adjusted to ~10<sup>8</sup> CFU/ml with TSB. TSB (200 &#181;l) and bacteria suspensions were used as a negative control and positive control, respectively. After loading the drug and bacteriostatic solution, the plate was incubated at 37&#176;C in an incubator for 24 h, and the absorbance at 580 nm was measured (<xref rid="b15-mmr-20-05-4067" ref-type="bibr">15</xref>).</p></sec><sec><title>Statistical analysis</title><p>All data are presented as the mean &#177; standard deviation (SD) from at least three independent experiments. GraphPad Prism 7.0 (GraphPad Software) was used for statistical analysis. Statistical differences between indicated groups were performed using one-way analysis of variance (ANOVA) followed by post hoc Tukey's test. P&lt;0.05 was considered to indicate a statistically significant difference.</p></sec></sec></sec><sec sec-type="results"><title>Results</title><sec><title/><sec><title>Replication of B. suis S2 in murine microglia BV2 cells</title><p>In order to investigate the growth of <italic toggle="yes">B. suis</italic> S2 in BV2 cells, BV2 cells were infected <italic toggle="yes">in vitro</italic> with MOI 100. It was revealed that there was a significant intracellular increase in CFUs 24 h post-infection (<xref rid="f1-mmr-20-05-4067" ref-type="fig">Fig. 1A</xref>), indicating the active growth of <italic toggle="yes">B. suis</italic> S2 in the murine microglial cells. In addition, there was no apoptosis of BV2 cells under light microscopy (data not shown) after bacterial infection, and the levels of LDH were not significantly altered 24 h post-infection (<xref rid="f1-mmr-20-05-4067" ref-type="fig">Fig. 1B</xref>).</p></sec><sec><title>Inhibition of caspase-dependent apoptosis after B. suis S2 infection</title><p>Western blot analysis revealed that the expression of cleaved caspase-3 was significantly decreased after <italic toggle="yes">B. suis</italic> S2 infection, but gradually increased as the infection period increased (<xref rid="f2-mmr-20-05-4067" ref-type="fig">Fig. 2</xref>). The present data indicated that <italic toggle="yes">Brucella</italic> may inhibit apoptosis of host cells for the infection.</p></sec><sec><title>Effects of DHA on BV2 cell viability</title><p>To observe the biological effects of DHA on BV2 cells, the cells were treated with different concentrations of DHA for 24 h. The results revealed that concentrations &lt;40 &#181;M DHA exhibited no inhibitory effects on cell viability (<xref rid="f3-mmr-20-05-4067" ref-type="fig">Fig. 3A</xref>). Moreover, cells were treated with 20 &#181;M DHA for various intervals, and no significant changes in cell viability were observed (<xref rid="f3-mmr-20-05-4067" ref-type="fig">Fig. 3B</xref>). The LDH assay demonstrated that a dose of DHA &lt;20 &#181;M had no inhibitory effects on BV2 cells (<xref rid="f3-mmr-20-05-4067" ref-type="fig">Fig. 3B</xref>).</p></sec><sec><title>DHA reduces B. suis S2 growth in BV2 cells</title><p>The present data revealed that intracellular growth of <italic toggle="yes">B. suis</italic> S2 could inhibit cell apoptosis of BV2 cells (unpublished data). Furthermore, CFU assay results of the treated BV2-infected cells with 10&#8211;40 &#181;M DHA revealed a significant and marked reduction in the <italic toggle="yes">B. suis</italic> S2 growth in the BV2 cells (<xref rid="f4-mmr-20-05-4067" ref-type="fig">Fig. 4</xref>).</p></sec><sec><title>DHA (20 &#181;M) inhibits bacterial multiplication by inducing apoptosis</title><p>The effects of DHA on <italic toggle="yes">B. suis</italic> S2 multiplication in BV2 cells were analyzed by the flow cytometric assay. The results revealed that 20 &#181;M DHA treatment increased the level of apoptosis in <italic toggle="yes">B. suis</italic> S2-infected BV2 cells (<xref rid="f5-mmr-20-05-4067" ref-type="fig">Fig. 5</xref>). Furthermore, western blot analysis revealed that 20 &#181;M of DHA treatment increased the expression of cleaved caspase-3 in <italic toggle="yes">B. suis</italic> S2-infected BV2 cells (<xref rid="f6-mmr-20-05-4067" ref-type="fig">Fig. 6</xref>). The present data indicated that DHA inhibited bacterial multiplication through induction of apoptosis in BV2 cells.</p></sec><sec><title>DHA does not directly inhibit or kill B. suis S2</title><p>To confirm whether DHA affects <italic toggle="yes">B. suis</italic> S2 growth directly or indirectly through apoptosis, an antibacterial susceptibility test was performed. The results revealed that different concentrations of DHA had no effect on bacterial growth (<xref rid="f7-mmr-20-05-4067" ref-type="fig">Fig. 7</xref>), indicating that DHA does not directly inhibit or kill <italic toggle="yes">B. suis</italic> S2. DHA did not exhibit any direct effects on bacterial growth, which supports our theory that the mechanism involved in the reduction of intracellular replication of BV2 cells by DHA may be achieved by promoting apoptosis of BV2 cells.</p></sec></sec></sec><sec sec-type="discussion"><title>Discussion</title><p><italic toggle="yes">Brucella</italic> is an intracellular bacterium that can cause chronic infections. It has been reported that infection of Brucella inhibits apoptosis of host cells (<xref rid="b16-mmr-20-05-4067" ref-type="bibr">16</xref>,<xref rid="b17-mmr-20-05-4067" ref-type="bibr">17</xref>). Therefore, it is necessary to investigate the mechanism underlying infection and develop therapeutic strategies for Brucellosis.</p><p>In the present study, it was demonstrated that <italic toggle="yes">B. suis</italic> S2 grew in BV2 cells without significant cytotoxicity, which is consistent with the characteristics of intracellular parasites. Previous studies revealed that <italic toggle="yes">Brucella</italic> outer membrane protein OMP25 inhibited apoptosis of host cells (<xref rid="b6-mmr-20-05-4067" ref-type="bibr">6</xref>). Similarly, this study confirmed that the caspase-dependent apoptotic pathway of BV2 cells was significantly inhibited after <italic toggle="yes">B. suis</italic> S2 infection, which provides a favorable condition for the intracellular replication of <italic toggle="yes">B. suis</italic> S2. This result is consistent with our findings on the mechanism of sustained infection for intracellular parasites, such as <italic toggle="yes">Mycobacterium tuberculosis</italic> (<xref rid="b18-mmr-20-05-4067" ref-type="bibr">18</xref>).</p><p>Apoptosis, programmed cell death, is indispensable for the development and homeostasis of multicellular organisms (<xref rid="b19-mmr-20-05-4067" ref-type="bibr">19</xref>). Caspase-3 is one of the activated caspases that catalyzes the cleavage of many key cellular proteins during apoptosis (<xref rid="b20-mmr-20-05-4067" ref-type="bibr">20</xref>). In the present study, western blot analysis revealed that the expression of cleaved caspase-3 was significantly decreased in BV2 cells after <italic toggle="yes">B. suis</italic> S2 infection, but gradually increased as the infection period increased. These observations indicated that <italic toggle="yes">Brucella</italic> may inhibit apoptosis of host cells for the infection. The present results are in agreement with the findings of <italic toggle="yes">Brucella</italic> in other types of cells (<xref rid="b21-mmr-20-05-4067" ref-type="bibr">21</xref>). Collectively, these data indicated that inhibition of host cell apoptosis may be a common strategy for <italic toggle="yes">Brucella</italic>-sustained infection. The underlying mechanisms of the DHA effect on bacteria remain unknown. Some studies suggest that the strategy of <italic toggle="yes">Brucella</italic> for infection establishment includes the following: i) to avoid intracellular destruction by limiting the fusion of the type IV secretion system-dependent vacuole-containing vacuoles to lysosomes; ii) inhibiting apoptosis of infected monocytes; and iii) inhibition of dendritic cell maturation, inhibition of antigen presentation and activation of naive T cells (<xref rid="b22-mmr-20-05-4067" ref-type="bibr">22</xref>). It is our aim to investigate the mechanisms in our future studies.</p><p>Conversely, DHA displays potent anti-viral and anti-parasitic activities (<xref rid="b23-mmr-20-05-4067" ref-type="bibr">23</xref>,<xref rid="b24-mmr-20-05-4067" ref-type="bibr">24</xref>), however, the molecular mechanisms are not fully understood yet. Artemisinin was also effective on bacteria. For example, oral administration of artesunate was revealed to reduce death from sepsis caused by E. coli (<xref rid="b25-mmr-20-05-4067" ref-type="bibr">25</xref>,<xref rid="b26-mmr-20-05-4067" ref-type="bibr">26</xref>). In combination with antibiotic oxacillin, oral administration of artesunate revealed a high effectiveness against mouse sepsis induced by methicillin-resistant aureus (MRSA). On the basis of previous findings, the inhibitory effects of DHA were evaluated on <italic toggle="yes">B. suis</italic> S2 <italic toggle="yes">in vitro</italic>. It was revealed that DHA inhibited <italic toggle="yes">B. suis</italic> S2 growth in BV2 cells. Furthermore, DHA increased the percentage of apoptosis and the expression/proteolytic degradation of caspase-3 in <italic toggle="yes">B. suis</italic> S2-infected cells. It is therefore concluded that DHA induces caspase-dependent apoptotic pathway activation to inhibit intracellular <italic toggle="yes">B. suis</italic> S2 growth.</p><p><italic toggle="yes">Brucella</italic> is an intracellular parasitic bacterium. In the present study, BV2 cells were infected with <italic toggle="yes">B. suis</italic> S2, and CFU experiments revealed that <italic toggle="yes">B. suis</italic> S2 grows in BV2 cells. After treatment with DHA, apoptosis of BV2 cell was increased. Additional experiments demonstrated that DHA had no direct effects on <italic toggle="yes">B. suis</italic> S2, which is similar to the effect of antibiotics on bacteria. Therefore, it is concluded that the mechanism involved in the reduction of intracellular replication of BV2 cells by DHA may be achieved by promoting apoptosis of BV2 cells.</p></sec></body><back><ack><title>Acknowledgements</title><p>Not applicable.</p></ack><sec><title>Funding</title><p>The present study was supported by grants from the National Natural Foundation of China (grant no. 31660030) and the First-Class Discipline Construction Project in Colleges and Universities of Ningxia (grant no. NXYLXK2017A05).</p></sec><sec sec-type="data-availability"><title>Availability of data and materials</title><p>The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.</p></sec><sec><title>Authors' contributions</title><p>JY, HL, ZhaW and ZheW conceived and designed the experiments. JY, HL, ZhaW, LY and QL conducted all the experiments. LY, QL, XN and TX contributed reagents, materials and analysis tools. XN and TX performed the experiments and were involved in the preliminary work. All authors read and approved the final manuscript.</p></sec><sec><title>Ethics approval and consent to participate</title><p>Not applicable.</p></sec><sec><title>Patient consent for publication</title><p>Not applicable.</p></sec><sec><title>Competing interests</title><p>The authors declare that they have no competing interests.</p></sec><ref-list><title>References</title><ref id="b1-mmr-20-05-4067"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>YJ</given-names></name><name name-style="western"><surname>Li</surname><given-names>XL</given-names></name><name name-style="western"><surname>Liang</surname><given-names>S</given-names></name><name name-style="western"><surname>Fang</surname><given-names>LQ</given-names></name><name name-style="western"><surname>Cao</surname><given-names>WC</given-names></name></person-group><article-title>Epidemiological features and risk factors associated with the spatial and temporal distribution of human brucellosis in China</article-title><source>BMC Infect Dis</source><volume>13</volume><fpage>547</fpage><year>2013</year><pub-id pub-id-type="doi">10.1186/1471-2334-13-547</pub-id><pub-id pub-id-type="pmid">24238301</pub-id><pub-id pub-id-type="pmcid">PMC3834885</pub-id></element-citation></ref><ref id="b2-mmr-20-05-4067"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sanodze</surname><given-names>L</given-names></name><name name-style="western"><surname>Bautista</surname><given-names>CT</given-names></name><name name-style="western"><surname>Garuchava</surname><given-names>N</given-names></name><name name-style="western"><surname>Chubinidze</surname><given-names>S</given-names></name><name name-style="western"><surname>Tsertsvadze</surname><given-names>E</given-names></name><name name-style="western"><surname>Broladze</surname><given-names>M</given-names></name><name name-style="western"><surname>Chitadze</surname><given-names>N</given-names></name><name name-style="western"><surname>Sidamonidze</surname><given-names>K</given-names></name><name name-style="western"><surname>Tsanava</surname><given-names>S</given-names></name><name name-style="western"><surname>Akhvlediani</surname><given-names>T</given-names></name><etal/></person-group><article-title>Expansion of brucellosis detection in the country of Georgia by screening household members of cases and neighboring community members</article-title><source>BMC Public Health</source><volume>15</volume><fpage>459</fpage><year>2015</year><pub-id pub-id-type="doi">10.1186/s12889-015-1761-y</pub-id><pub-id pub-id-type="pmid">25934639</pub-id><pub-id pub-id-type="pmcid">PMC4432945</pub-id></element-citation></ref><ref id="b3-mmr-20-05-4067"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tuon</surname><given-names>FF</given-names></name><name name-style="western"><surname>Gondolfo</surname><given-names>RB</given-names></name><name name-style="western"><surname>Cerchiari</surname><given-names>N</given-names></name></person-group><article-title>Human-to-human transmission of Brucella-a systematic review</article-title><source>Trop Med Int Health</source><volume>22</volume><fpage>539</fpage><lpage>546</lpage><year>2017</year><pub-id pub-id-type="doi">10.1111/tmi.12856</pub-id><pub-id pub-id-type="pmid">28196298</pub-id></element-citation></ref><ref id="b4-mmr-20-05-4067"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zheng</surname><given-names>R</given-names></name><name name-style="western"><surname>Xie</surname><given-names>S</given-names></name><name name-style="western"><surname>Lu</surname><given-names>X</given-names></name><name name-style="western"><surname>Sun</surname><given-names>L</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wang</surname><given-names>K</given-names></name></person-group><article-title>A systematic review and meta-analysis of epidemiology and clinical manifestations of human brucellosis in China</article-title><source>Biomed Res Int</source><volume>2018</volume><fpage>5712920</fpage><year>2018</year><pub-id pub-id-type="doi">10.1155/2018/5712920</pub-id><pub-id pub-id-type="pmid">29850535</pub-id><pub-id pub-id-type="pmcid">PMC5937618</pub-id></element-citation></ref><ref id="b5-mmr-20-05-4067"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Elfaki</surname><given-names>MG</given-names></name><name name-style="western"><surname>Alaidan</surname><given-names>AA</given-names></name><name name-style="western"><surname>Al-Hokail</surname><given-names>AA</given-names></name></person-group><article-title>Host response to Brucella infection: Review and future perspective</article-title><source>J Infect Dev Ctries</source><volume>9</volume><fpage>697</fpage><lpage>701</lpage><year>2015</year><pub-id pub-id-type="doi">10.3855/jidc.6625</pub-id><pub-id pub-id-type="pmid">26230118</pub-id></element-citation></ref><ref id="b6-mmr-20-05-4067"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ma</surname><given-names>QL</given-names></name><name name-style="western"><surname>Liu</surname><given-names>AC</given-names></name><name name-style="western"><surname>Ma</surname><given-names>XJ</given-names></name><name name-style="western"><surname>Wang</surname><given-names>YB</given-names></name><name name-style="western"><surname>Hou</surname><given-names>YT</given-names></name><name name-style="western"><surname>Wang</surname><given-names>ZH</given-names></name></person-group><article-title>Brucella outer membrane protein Omp25 induces microglial cells in vitro to secrete inflammatory cytokines and inhibit apoptosis</article-title><source>Int J Clin Exp Med</source><volume>8</volume><fpage>17530</fpage><lpage>17535</lpage><year>2015</year><pub-id pub-id-type="pmid">26770344</pub-id><pub-id pub-id-type="pmcid">PMC4694244</pub-id></element-citation></ref><ref id="b7-mmr-20-05-4067"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>XG</given-names></name><name name-style="western"><surname>Li</surname><given-names>GX</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>SS</given-names></name><name name-style="western"><surname>Xu</surname><given-names>FL</given-names></name><name name-style="western"><surname>Wang</surname><given-names>YH</given-names></name><name name-style="western"><surname>Wang</surname><given-names>W</given-names></name></person-group><article-title>A review of dihydroartemisinin as another gift from traditional Chinese medicine not only for malaria control but also for schistosomiasis control</article-title><source>Parasitol Res</source><volume>113</volume><fpage>1769</fpage><lpage>1773</lpage><year>2014</year><pub-id pub-id-type="doi">10.1007/s00436-014-3822-z</pub-id><pub-id pub-id-type="pmid">24609234</pub-id></element-citation></ref><ref id="b8-mmr-20-05-4067"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dong</surname><given-names>F</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>X</given-names></name><name name-style="western"><surname>Li</surname><given-names>C</given-names></name><name name-style="western"><surname>Yan</surname><given-names>S</given-names></name><name name-style="western"><surname>Deng</surname><given-names>X</given-names></name><name name-style="western"><surname>Cao</surname><given-names>Z</given-names></name><name name-style="western"><surname>Li</surname><given-names>L</given-names></name><name name-style="western"><surname>Tang</surname><given-names>B</given-names></name><name name-style="western"><surname>Allen</surname><given-names>TD</given-names></name><name name-style="western"><surname>Liu</surname><given-names>J</given-names></name></person-group><article-title>Dihydroartemisinin targets VEGFR2 via the NF-&#954;B pathway in endothelial cells to inhibit angiogenesis</article-title><source>Cancer Biol Ther</source><volume>15</volume><fpage>1479</fpage><lpage>1488</lpage><year>2014</year><pub-id pub-id-type="doi">10.4161/15384047.2014.955728</pub-id><pub-id pub-id-type="pmid">25482945</pub-id><pub-id pub-id-type="pmcid">PMC4623302</pub-id></element-citation></ref><ref id="b9-mmr-20-05-4067"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name><name name-style="western"><surname>Guo</surname><given-names>L</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>X</given-names></name><name name-style="western"><surname>Dong</surname><given-names>F</given-names></name><name name-style="western"><surname>Li</surname><given-names>L</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>Z</given-names></name><name name-style="western"><surname>Xu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Liang</surname><given-names>J</given-names></name><name name-style="western"><surname>Xie</surname><given-names>Q</given-names></name><name name-style="western"><surname>Liu</surname><given-names>J</given-names></name></person-group><article-title>Dihydroartemisinin induces endothelial cell anoikis through the activation of the JNK signaling pathway</article-title><source>Oncol Lett</source><volume>12</volume><fpage>1896</fpage><lpage>1900</lpage><year>2016</year><pub-id pub-id-type="doi">10.3892/ol.2016.4870</pub-id><pub-id pub-id-type="pmid">27602117</pub-id><pub-id pub-id-type="pmcid">PMC4998146</pub-id></element-citation></ref><ref id="b10-mmr-20-05-4067"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Im</surname><given-names>E</given-names></name><name name-style="western"><surname>Yeo</surname><given-names>C</given-names></name><name name-style="western"><surname>Lee</surname><given-names>HJ</given-names></name><name name-style="western"><surname>Lee</surname><given-names>EO</given-names></name></person-group><article-title>Dihydroartemisinin induced caspase-dependent apoptosis through inhibiting the specificity protein 1 pathway in hepatocellular carcinoma SK-Hep-1 cells</article-title><source>Life Sci</source><volume>192</volume><fpage>286</fpage><lpage>292</lpage><year>2018</year><pub-id pub-id-type="doi">10.1016/j.lfs.2017.11.008</pub-id><pub-id pub-id-type="pmid">29128513</pub-id></element-citation></ref><ref id="b11-mmr-20-05-4067"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><name name-style="western"><surname>Lin</surname><given-names>P</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y</given-names></name><name name-style="western"><surname>Xiang</surname><given-names>C</given-names></name><name name-style="western"><surname>Yin</surname><given-names>Y</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Z</given-names></name><name name-style="western"><surname>Du</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>D</given-names></name><name name-style="western"><surname>Jin</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wang</surname><given-names>A</given-names></name></person-group><article-title>Brucella suis vaccine strain 2 induces endoplasmic reticulum stress that affects intracellular replication in goat trophoblast cells in vitro</article-title><source>Front Cell Infect Microbiol</source><volume>6</volume><fpage>19</fpage><year>2016</year><pub-id pub-id-type="doi">10.3389/fcimb.2016.00019</pub-id><pub-id pub-id-type="pmid">26904517</pub-id><pub-id pub-id-type="pmcid">PMC4746994</pub-id></element-citation></ref><ref id="b12-mmr-20-05-4067"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>M</given-names></name><name name-style="western"><surname>Yu</surname><given-names>X</given-names></name><name name-style="western"><surname>Guo</surname><given-names>H</given-names></name><name name-style="western"><surname>Sun</surname><given-names>L</given-names></name><name name-style="western"><surname>Wang</surname><given-names>A</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Q</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><name name-style="western"><surname>Li</surname><given-names>J</given-names></name></person-group><article-title>Bufalin exerts antitumor effects by inducing cell cycle arrest and triggering apoptosis in pancreatic cancer cells</article-title><source>Tumour Biol</source><volume>35</volume><fpage>2461</fpage><lpage>2471</lpage><year>2014</year><pub-id pub-id-type="doi">10.1007/s13277-013-1326-6</pub-id><pub-id pub-id-type="pmid">24218335</pub-id></element-citation></ref><ref id="b13-mmr-20-05-4067"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hang</surname><given-names>R</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>M</given-names></name><name name-style="western"><surname>Ma</surname><given-names>S</given-names></name><name name-style="western"><surname>Chu</surname><given-names>PK</given-names></name></person-group><article-title>Biological response of endothelial cells to diamond-like carbon-coated NiTi alloy</article-title><source>J Biomed Mater Res A</source><volume>100</volume><fpage>496</fpage><lpage>506</lpage><year>2012</year><pub-id pub-id-type="doi">10.1002/jbm.a.33295</pub-id><pub-id pub-id-type="pmid">22125203</pub-id></element-citation></ref><ref id="b14-mmr-20-05-4067"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zahedifard</surname><given-names>M</given-names></name><name name-style="western"><surname>Faraj</surname><given-names>FL</given-names></name><name name-style="western"><surname>Paydar</surname><given-names>M</given-names></name><name name-style="western"><surname>Yeng Looi</surname><given-names>C</given-names></name><name name-style="western"><surname>Hajrezaei</surname><given-names>M</given-names></name><name name-style="western"><surname>Hasanpourghadi</surname><given-names>M</given-names></name><name name-style="western"><surname>Kamalidehghan</surname><given-names>B</given-names></name><name name-style="western"><surname>Abdul Majid</surname><given-names>N</given-names></name><name name-style="western"><surname>Mohd Ali</surname><given-names>H</given-names></name><name name-style="western"><surname>Ameen Abdulla</surname><given-names>M</given-names></name></person-group><article-title>Synthesis, characterization and apoptotic activity of quinazolinone Schiff base derivatives toward MCF-7 cells via intrinsic and extrinsic apoptosis pathways</article-title><source>Sci Rep</source><volume>5</volume><fpage>11544</fpage><year>2015</year><pub-id pub-id-type="doi">10.1038/srep11544</pub-id><pub-id pub-id-type="pmid">26108872</pub-id><pub-id pub-id-type="pmcid">PMC4479988</pub-id></element-citation></ref><ref id="b15-mmr-20-05-4067"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lin</surname><given-names>Z</given-names></name><name name-style="western"><surname>Xu</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>S</given-names></name><name name-style="western"><surname>Yang</surname><given-names>X</given-names></name><name name-style="western"><surname>Guo</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Q</given-names></name><name name-style="western"><surname>Jing</surname><given-names>C</given-names></name><name name-style="western"><surname>Chen</surname><given-names>S</given-names></name><name name-style="western"><surname>He</surname><given-names>Y</given-names></name></person-group><article-title>Total synthesis and antimicrobial evaluation of natural albomycins against clinical pathogens</article-title><source>Nat Commun</source><volume>9</volume><fpage>3445</fpage><year>2018</year><pub-id pub-id-type="doi">10.1038/s41467-018-05821-1</pub-id><pub-id pub-id-type="pmid">30181560</pub-id><pub-id pub-id-type="pmcid">PMC6123416</pub-id></element-citation></ref><ref id="b16-mmr-20-05-4067"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pujol</surname><given-names>M</given-names></name><name name-style="western"><surname>Castillo</surname><given-names>F</given-names></name><name name-style="western"><surname>Alvarez</surname><given-names>C</given-names></name><name name-style="western"><surname>Rojas</surname><given-names>C</given-names></name><name name-style="western"><surname>Borie</surname><given-names>C</given-names></name><name name-style="western"><surname>Ferreira</surname><given-names>A</given-names></name><name name-style="western"><surname>Vernal</surname><given-names>R</given-names></name></person-group><article-title>Variability in the response of canine and human dendritic cells stimulated with Brucella canis</article-title><source>Vet Res</source><volume>48</volume><fpage>72</fpage><year>2017</year><pub-id pub-id-type="doi">10.1186/s13567-017-0476-8</pub-id><pub-id pub-id-type="pmid">29096717</pub-id><pub-id pub-id-type="pmcid">PMC5667440</pub-id></element-citation></ref><ref id="b17-mmr-20-05-4067"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Miller</surname><given-names>CN</given-names></name><name name-style="western"><surname>Smith</surname><given-names>EP</given-names></name><name name-style="western"><surname>Cundiff</surname><given-names>JA</given-names></name><name name-style="western"><surname>Knodler</surname><given-names>LA</given-names></name><name name-style="western"><surname>Bailey Blackburn</surname><given-names>J</given-names></name><name name-style="western"><surname>Lupashin</surname><given-names>V</given-names></name><name name-style="western"><surname>Celli</surname><given-names>J</given-names></name></person-group><article-title>A brucella type IV effector targets the COG tethering complex to remodel host secretory traffic and promote intracellular replication</article-title><source>Cell Host Microbe</source><volume>22</volume><fpage>317.e7</fpage><lpage>329.e7</lpage><year>2017</year><pub-id pub-id-type="doi">10.1016/j.chom.2017.07.017</pub-id><pub-id pub-id-type="pmid">28844886</pub-id><pub-id pub-id-type="pmcid">PMC5599354</pub-id></element-citation></ref><ref id="b18-mmr-20-05-4067"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fan</surname><given-names>L</given-names></name><name name-style="western"><surname>Wu</surname><given-names>X</given-names></name><name name-style="western"><surname>Jin</surname><given-names>C</given-names></name><name name-style="western"><surname>Li</surname><given-names>F</given-names></name><name name-style="western"><surname>Xiong</surname><given-names>S</given-names></name><name name-style="western"><surname>Dong</surname><given-names>Y</given-names></name></person-group><article-title>MptpB promotes mycobacteria survival by inhibiting the expression of inflammatory mediators and cell apoptosis in macrophages</article-title><source>Front Cell Infect Microbiol</source><volume>8</volume><fpage>171</fpage><year>2018</year><pub-id pub-id-type="doi">10.3389/fcimb.2018.00171</pub-id><pub-id pub-id-type="pmid">29888212</pub-id><pub-id pub-id-type="pmcid">PMC5981270</pub-id></element-citation></ref><ref id="b19-mmr-20-05-4067"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kopeina</surname><given-names>GS</given-names></name><name name-style="western"><surname>Prokhorova</surname><given-names>EA</given-names></name><name name-style="western"><surname>Lavrik</surname><given-names>IN</given-names></name><name name-style="western"><surname>Zhivotovsky</surname><given-names>B</given-names></name></person-group><article-title>Alterations in the nucleocytoplasmic transport in apoptosis: Caspases lead the way</article-title><source>Cell Prolif</source><volume>51</volume><fpage>e12467</fpage><year>2018</year><pub-id pub-id-type="doi">10.1111/cpr.12467</pub-id><pub-id pub-id-type="pmid">29947118</pub-id><pub-id pub-id-type="pmcid">PMC6528946</pub-id></element-citation></ref><ref id="b20-mmr-20-05-4067"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Julien</surname><given-names>O</given-names></name><name name-style="western"><surname>Zhuang</surname><given-names>M</given-names></name><name name-style="western"><surname>Wiita</surname><given-names>AP</given-names></name><name name-style="western"><surname>O'Donoghue</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Knudsen</surname><given-names>GM</given-names></name><name name-style="western"><surname>Craik</surname><given-names>CS</given-names></name><name name-style="western"><surname>Wells</surname><given-names>JA</given-names></name></person-group><article-title>Quantitative MS-based enzymology of caspases reveals distinct protein substrate specificities, hierarchies, and cellular roles</article-title><source>Proc Natl Acad Sci USA</source><volume>113</volume><fpage>E2001</fpage><lpage>E2010</lpage><year>2016</year><pub-id pub-id-type="doi">10.1073/pnas.1524900113</pub-id><pub-id pub-id-type="pmid">27006500</pub-id><pub-id pub-id-type="pmcid">PMC4833263</pub-id></element-citation></ref><ref id="b21-mmr-20-05-4067"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cui</surname><given-names>G</given-names></name><name name-style="western"><surname>Wei</surname><given-names>P</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Guan</surname><given-names>Z</given-names></name><name name-style="western"><surname>Yang</surname><given-names>L</given-names></name><name name-style="western"><surname>Sun</surname><given-names>W</given-names></name><name name-style="western"><surname>Wang</surname><given-names>S</given-names></name><name name-style="western"><surname>Peng</surname><given-names>Q</given-names></name></person-group><article-title>Brucella infection inhibits macrophages apoptosis via Nedd4-dependent degradation of calpain2</article-title><source>Vet Microbiol</source><volume>174</volume><fpage>195</fpage><lpage>205</lpage><year>2014</year><pub-id pub-id-type="doi">10.1016/j.vetmic.2014.08.033</pub-id><pub-id pub-id-type="pmid">25258171</pub-id></element-citation></ref><ref id="b22-mmr-20-05-4067"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>de Figueiredo</surname><given-names>P</given-names></name><name name-style="western"><surname>Ficht</surname><given-names>TA</given-names></name><name name-style="western"><surname>Rice-Ficht</surname><given-names>A</given-names></name><name name-style="western"><surname>Rossetti</surname><given-names>CA</given-names></name><name name-style="western"><surname>Adams</surname><given-names>LG</given-names></name></person-group><article-title>Pathogenesis and immunobiology of brucellosis: Review of Brucella-host interactions</article-title><source>Am J Pathol</source><volume>185</volume><fpage>1505</fpage><lpage>1517</lpage><year>2015</year><pub-id pub-id-type="doi">10.1016/j.ajpath.2015.03.003</pub-id><pub-id pub-id-type="pmid">25892682</pub-id><pub-id pub-id-type="pmcid">PMC4450313</pub-id></element-citation></ref><ref id="b23-mmr-20-05-4067"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Efferth</surname><given-names>T</given-names></name><name name-style="western"><surname>Romero</surname><given-names>MR</given-names></name><name name-style="western"><surname>Wolf</surname><given-names>DG</given-names></name><name name-style="western"><surname>Stamminger</surname><given-names>T</given-names></name><name name-style="western"><surname>Marin</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Marschall</surname><given-names>M</given-names></name></person-group><article-title>The antiviral activities of artemisinin and artesunate</article-title><source>Clin Infect Dis</source><volume>47</volume><fpage>804</fpage><lpage>811</lpage><year>2008</year><pub-id pub-id-type="doi">10.1086/591195</pub-id><pub-id pub-id-type="pmid">18699744</pub-id></element-citation></ref><ref id="b24-mmr-20-05-4067"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lam</surname><given-names>NS</given-names></name><name name-style="western"><surname>Long</surname><given-names>X</given-names></name><name name-style="western"><surname>Su</surname><given-names>XZ</given-names></name><name name-style="western"><surname>Lu</surname><given-names>F</given-names></name></person-group><article-title>Artemisinin and its derivatives in treating helminthic infections beyond schistosomiasis</article-title><source>Pharmacol Res</source><volume>133</volume><fpage>77</fpage><lpage>100</lpage><year>2018</year><pub-id pub-id-type="doi">10.1016/j.phrs.2018.04.025</pub-id><pub-id pub-id-type="pmid">29727708</pub-id></element-citation></ref><ref id="b25-mmr-20-05-4067"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>H</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>J</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>J</given-names></name><name name-style="western"><surname>Liu</surname><given-names>W</given-names></name><name name-style="western"><surname>Ding</surname><given-names>G</given-names></name><name name-style="western"><surname>Wang</surname><given-names>L</given-names></name><name name-style="western"><surname>Luo</surname><given-names>P</given-names></name><name name-style="western"><surname>Lu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Cao</surname><given-names>H</given-names></name><etal/></person-group><article-title>The antimalarial artemisinin synergizes with antibiotics to protect against lethal live Escherichia coli challenge by decreasing proinflammatory cytokine release</article-title><source>Antimicrob Agents Chemother</source><volume>50</volume><fpage>2420</fpage><lpage>2427</lpage><year>2016</year><pub-id pub-id-type="doi">10.1128/AAC.01066-05</pub-id><pub-id pub-id-type="pmcid">PMC1489802</pub-id><pub-id pub-id-type="pmid">16801421</pub-id></element-citation></ref><ref id="b26-mmr-20-05-4067"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jiang</surname><given-names>W</given-names></name><name name-style="western"><surname>Li</surname><given-names>B</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>X</given-names></name><name name-style="western"><surname>Liu</surname><given-names>X</given-names></name><name name-style="western"><surname>Cen</surname><given-names>Y</given-names></name><name name-style="western"><surname>Li</surname><given-names>J</given-names></name><name name-style="western"><surname>Pan</surname><given-names>X</given-names></name><name name-style="western"><surname>Cao</surname><given-names>H</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>H</given-names></name></person-group><article-title>Artesunate in combination with oxacillin protect sepsis model mice challenged with lethal live methicillin-resistant Staphylococcus aureus (MRSA) via its inhibition on proinflammatory cytokines release and enhancement on antibacterial activity of oxacillin</article-title><source>Int Immunopharmacol</source><volume>11</volume><fpage>1065</fpage><lpage>1073</lpage><year>2011</year><pub-id pub-id-type="doi">10.1016/j.intimp.2011.02.028</pub-id><pub-id pub-id-type="pmid">21396483</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="f1-mmr-20-05-4067" orientation="portrait" position="float"><label>Figure 1.</label><caption><p>Growth of <italic toggle="yes">B. suis</italic> S2 in BV2 cells and cellular LDH release. (A) Cells were infected with <italic toggle="yes">B. suis</italic> S2 by MOI 100 for 24 h. Growth of bacteria was evaluated by CFU assay. Data are reported as the mean &#177; SD. (B) Supernatants of BV2 cells from indicated groups were collected and evaluated for LDH. Data are reported as the mean &#177; SD. <italic toggle="yes">B. suis</italic> S2, <italic toggle="yes">B. suis</italic> vaccine strain 2; LDH, lactate dehydrogenase; MOI; multiplicity of infection; CFU, colony-forming unit.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="MMR-20-05-4067-g00.jpg"/></fig><fig id="f2-mmr-20-05-4067" orientation="portrait" position="float"><label>Figure 2.</label><caption><p>Western blot analysis of caspase-dependent apoptosis-associated proteins. (A) Representative blots of three independent experiments are presented, and the protein size is expressed in kDa. (B) Quantification of cleaved caspase-3 protein levels from three separate experiments, normalized to GAPDH. **P&lt;0.01, ***P&lt;0.001 vs. BV2 control cells.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="MMR-20-05-4067-g01.jpg"/></fig><fig id="f3-mmr-20-05-4067" orientation="portrait" position="float"><label>Figure 3.</label><caption><p>Effects of DHA on BV2 cells. (A) Cells were treated with various concentrations of DHA for 24 h, and cell viability was evaluated by CCK-8 assay. (B) Cells were treated with 20 &#181;M DHA for indicated time-points, and cell viability was evaluated by CCK-8 assay. (C) Cells were treated with various concentrations of DHA for 24 h, and cell toxicity was evaluated by LDH release. ***P&lt;0.001 vs. the control. DHA, dihydroartemisinin; LDH, lactate dehydrogenase.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="MMR-20-05-4067-g02.jpg"/></fig><fig id="f4-mmr-20-05-4067" orientation="portrait" position="float"><label>Figure 4.</label><caption><p>Effects of DHA on the <italic toggle="yes">B. suis</italic> S2 growth in BV2 cells. DHA significantly inhibited the growth of <italic toggle="yes">B. suis</italic> S2 in BV2 cells. ****P&lt;0.0001 vs. the untreated BV2-infected group. DHA, dihydroartemisinin; <italic toggle="yes">B. suis</italic> S2, <italic toggle="yes">B. suis</italic> vaccine strain 2.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="MMR-20-05-4067-g03.jpg"/></fig><fig id="f5-mmr-20-05-4067" orientation="portrait" position="float"><label>Figure 5.</label><caption><p>Effects of 20 &#181;M DHA on intracellular <italic toggle="yes">B. suis</italic> S2 multiplication and BV2 cellular apoptosis. (A) The effects of 20 &#181;M DHA on the <italic toggle="yes">B. suis</italic> S2 growth in BV2 cells. (B) Percentage of BV2 cell apoptosis was determined by flow cytometric assay. Different quadrants exhibit the percentage of viable cells as determined by scattering profiles of flow cytometric assay. (C) Values are expressed as the means &#177; SD of three individual experiments. *P&lt;0.05, ***P&lt;0.001. DHA, dihydroartemisinin; <italic toggle="yes">B. suis</italic> S2, <italic toggle="yes">B. suis</italic> vaccine strain 2; CFU, colony-forming unit.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="MMR-20-05-4067-g04.jpg"/></fig><fig id="f6-mmr-20-05-4067" orientation="portrait" position="float"><label>Figure 6.</label><caption><p>Western blot analysis of the caspase-dependent apoptosis in <italic toggle="yes">B. suis</italic> S2-infected BV2 cells. (A) Representative blots of three independent experiments are presented, and the protein size is expressed in kDa. (B) Densitometric quantification data are expressed as the intensity ratio of target proteins to GAPDH. *P&lt;0.05. CFU, colony-forming unit; DHA, dihydroartemisinin; <italic toggle="yes">B. suis</italic> S2, <italic toggle="yes">B. suis</italic> vaccine strain 2.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="MMR-20-05-4067-g05.jpg"/></fig><fig id="f7-mmr-20-05-4067" orientation="portrait" position="float"><label>Figure 7.</label><caption><p>Antibacterial susceptibility test performed for the <italic toggle="yes">B. suis</italic> S2-infected cells. Cells were treated with indicated concentrations of DHA. TSB (200 &#181;l) and bacteria suspensions were used as a negative control and a positive control, respectively. <italic toggle="yes">B. suis</italic> S2, <italic toggle="yes">B. suis</italic> vaccine strain 2; DHA, dihydroartemisinin; TSB, tryptic soy broth.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="MMR-20-05-4067-g06.jpg"/></fig></floats-group></article></pmc-articleset>